0001127602-21-010168.txt : 20210310
0001127602-21-010168.hdr.sgml : 20210310
20210310210152
ACCESSION NUMBER: 0001127602-21-010168
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210308
FILED AS OF DATE: 20210310
DATE AS OF CHANGE: 20210310
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PAPA JOSEPH C
CENTRAL INDEX KEY: 0001242215
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14956
FILM NUMBER: 21731550
MAIL ADDRESS:
STREET 1: C/O WATSON PHARMACEUTICALS INC
STREET 2: 311 BONNIE CIRCLE
CITY: CORONA
STATE: CA
ZIP: 92880
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bausch Health Companies Inc.
CENTRAL INDEX KEY: 0000885590
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
BUSINESS PHONE: 514-744-6792
MAIL ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
FORMER COMPANY:
FORMER CONFORMED NAME: Valeant Pharmaceuticals International, Inc.
DATE OF NAME CHANGE: 20100928
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL Corp
DATE OF NAME CHANGE: 20100416
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL
DATE OF NAME CHANGE: 19960522
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2021-03-08
0000885590
Bausch Health Companies Inc.
BHC
0001242215
PAPA JOSEPH C
400 SOMERSET CORPORATE BOULEVARD
BRIDGEWATER
NJ
08807
1
1
CHAIRMAN & CEO
Common Shares, No Par Value
2021-03-08
4
M
0
317089
A
1162912
D
Common Shares, No Par Value
2021-03-08
4
A
0
108254
0
A
1271166
D
Common Shares, No Par Value
2021-03-10
4
F
0
231188
32.97
D
1039978
D
Restricted Share Units
2021-03-08
4
M
0
317089
D
2021-03-07
Common Stock
317089
0
D
Reflects common shares, no par value ("Common Shares") of Bausch Health Companies Inc. (the "Company") issued to the reporting person following the vesting of, and certification of performance metrics relating to, performance-based Restricted Share Units ("PSUs") granted to the reporting person on March 7, 2018.
Each PSU converts into Common Shares on a one-for-one basis.
This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of PSUs and RSUs.
The PSUs granted to the reporting person on March 7, 2018 were distributed on March 10, 2021 following certification of the achievement of certain performance metrics.
This PSU award was previously reported on a Form 4 filed on March 9, 2018 with the maximum potential award amount of 511,434 shares. Any portion of the award not vested as of the transaction date was cancelled as of that date.
/s/ Kirsten O'Donnell, attorney-in-fact for Joseph C. Papa
2021-03-10